Leerink partners and Truist Financial issued research reports, including buy ratings and price objective lifts, regarding Absci Corporation's stock.
2 reports, 1 independent
Updated Jul 23
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leerink partners and Truist Financial issued research reports, including buy ratings and price objective lifts, regarding Absci Corporation's stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Leerink partners
U.S. investment bank
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Keefe, Bruyette & Woods issued a research report and aggregated consensus ratings for TriplePoint Venture Growth BDC stock.
- Truist Financial and Citigroup provided buy ratings and price objectives for Crown stock.
- MarketBeat aggregated analyst reports on Best Buy stock on September 13, 2026.
- MarketBeat aggregated analyst ratings on ENI stock on August 31, 2026.
- MarketBeat reported recent stock ratings for Innovative Solutions and Support, Inc. and TechPrecision Corporation.